Christine M. Rousseau, Ph.D. joined Chembio Diagnostics Systems, Inc. in July of 2018 as Vice President, Corporate Development. Prior to joining Chembio, Dr. Rousseau spent nine years at the Bill & Melinda Gates Foundation, most recently serving as Senior Program Officer, Global Health, Integrated Technology Solutions. While there, she directed over $250 million in assets for the development, commercialization, and scale-up of immune, molecular and cellular diagnostic technologies, including a significant role in HIV Self-Testing. In addition, Dr. Rousseau spent over ten years as a research scientist and faculty member at the University of Washington, with emphasis in the areas of HIV and HCV. Earlier in her career, she was a Senior Fellow at the Fred Hutchinson Cancer Research Center and HIV Director & Founding Board Member of the Sustainable Sciences Institute.